Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 163

1.

Remission as perceived by people with schizophrenia, family members and psychiatrists.

Karow A, Naber D, Lambert M, Moritz S; EGOFORS Initiative..

Eur Psychiatry. 2012 Aug;27(6):426-31. doi: 10.1016/j.eurpsy.2011.01.013.

PMID:
21571506
2.

Remitted but still impaired? Symptomatic versus functional remission in patients with schizophrenia.

Karow A, Moritz S, Lambert M, Schöttle D, Naber D; EGOFORS Initiative..

Eur Psychiatry. 2012 Aug;27(6):401-5. doi: 10.1016/j.eurpsy.2011.01.012.

PMID:
21570262
3.
4.

Quality of life and subjective well-being in schizophrenia and schizophrenia spectrum disorders: valid predictors of symptomatic response and remission?

Schennach-Wolff R, Jäger M, Obermeier M, Schmauss M, Laux G, Pfeiffer H, Naber D, Schmidt LG, Gaebel W, Klosterkötter J, Heuser I, Kühn KU, Lemke MR, Rüther E, Klingberg S, Gastpar M, Seemüller F, Möller HJ, Riedel M.

World J Biol Psychiatry. 2010 Aug;11(5):729-38. doi: 10.3109/15622971003690289.

PMID:
20380620
5.

Negative symptoms and psychosocial functioning in schizophrenia: neglected but important targets for treatment.

Hunter R, Barry S.

Eur Psychiatry. 2012 Aug;27(6):432-6. doi: 10.1016/j.eurpsy.2011.02.015.

PMID:
21602034
6.

Employment and its relationship with functionality and quality of life in patients with schizophrenia: EGOFORS Study.

Üçok A, Gorwood P, Karadayı G; EGOFORS..

Eur Psychiatry. 2012 Aug;27(6):422-5. doi: 10.1016/j.eurpsy.2011.01.014.

PMID:
21592736
7.

Establishing remission and good clinical functioning in schizophrenia: predictors of best outcome with long-term risperidone long-acting injectable treatment.

Lambert M, De Marinis T, Pfeil J, Naber D, Schreiner A.

Eur Psychiatry. 2010 May;25(4):220-9. doi: 10.1016/j.eurpsy.2009.09.001.

PMID:
19926263
8.

Quality of life and subjective well-being during treatment with antipsychotics in out-patients with schizophrenia.

Wehmeier PM, Kluge M, Schneider E, Schacht A, Wagner T, Schreiber W.

Prog Neuropsychopharmacol Biol Psychiatry. 2007 Apr 13;31(3):703-12.

PMID:
17289237
9.

Response and remission of subjective well-being in patients suffering from schizophrenia spectrum disorders.

Schennach-Wolff R, Seemüller F, Obermeier M, Messer T, Laux G, Pfeiffer H, Naber D, Schmidt LG, Gaebel W, Klosterkötter J, Heuser I, Maier W, Lemke MR, Rüther E, Buchkremer G, Gastpar M, Jäger M, Möller HJ, Riedel M.

Eur Psychiatry. 2011 Jul-Aug;26(5):284-92. doi: 10.1016/j.eurpsy.2009.11.005.

PMID:
20435447
10.

Subjective assessments of the quality of life, well-being and self-efficacy in patients with schizophrenia.

Chino B, Nemoto T, Fujii C, Mizuno M.

Psychiatry Clin Neurosci. 2009 Aug;63(4):521-8. doi: 10.1111/j.1440-1819.2009.01995.x.

11.

[Caregiver burden in relatives of persons with schizophrenia: an overview of measure instruments].

Reine G, Lancon C, Simeoni MC, Duplan S, Auquier P.

Encephale. 2003 Mar-Apr;29(2):137-47. Review. French.

PMID:
14567165
12.

Improvement of subjective well-being and enduring symptomatic remission, a 5-year follow-up of first episode schizophrenia.

de Haan L, Nimwegen Lv, Amelsvoort Tv, Dingemans P, Linszen D.

Pharmacopsychiatry. 2008 Jul;41(4):125-8. doi: 10.1055/s-2008-1076729.

PMID:
18651339
13.

Symptomatic remission in previously untreated patients with schizophrenia: 2-year results from the SOHO study.

Novick D, Haro JM, Suarez D, Lambert M, Lépine JP, Naber D.

Psychopharmacology (Berl). 2007 May;191(4):1015-22.

PMID:
17310386
14.
15.

[Relationship between insight and self-reported quality of life among shizophrenic patients].

Aghababian V, Auquier P, Baumstarck-Barrau K, Lançon C.

Encephale. 2011 Jun;37(3):162-71. doi: 10.1016/j.encep.2010.08.011. French.

PMID:
21703431
16.

Randomised controlled trials of conventional antipsychotic versus new atypical drugs, and new atypical drugs versus clozapine, in people with schizophrenia responding poorly to, or intolerant of, current drug treatment.

Lewis SW, Davies L, Jones PB, Barnes TR, Murray RM, Kerwin R, Taylor D, Hayhurst KP, Markwick A, Lloyd H, Dunn G.

Health Technol Assess. 2006 May;10(17):iii-iv, ix-xi, 1-165.

17.

Is it true remission? A study of remitted patients affected by schizophrenia and schizoaffective disorders.

Pinna F, Deriu L, Lepori T, Maccioni R, Milia P, Sarritzu E, Tusconi M, Carpiniello B; Cagliari Recovery Study Group..

Psychiatry Res. 2013 Dec 30;210(3):739-44. doi: 10.1016/j.psychres.2013.08.022.

PMID:
24007858
18.

Sustained favorable long-term outcome in the treatment of schizophrenia: a 3-year prospective observational study.

Cuyún Carter GB, Milton DR, Ascher-Svanum H, Faries DE.

BMC Psychiatry. 2011 Aug 26;11:143. doi: 10.1186/1471-244X-11-143.

19.

[Negative symptoms of schizophrenic patients from the perspective of psychiatrists, patients themselves and their relatives].

Bottlender R, Jäger M, Kunze I, Groll C, Borski I, Möller HJ.

Nervenarzt. 2003 Sep;74(9):762-6. German.

PMID:
14504774
20.

Symptomatic resolution among Chinese patients with schizophrenia and associated factors.

Li CT, Su TP, Chou YH, Lee YC, Liu ME, Ku HL, Shan IK, Bai YM.

J Formos Med Assoc. 2010 May;109(5):378-88. doi: 10.1016/S0929-6646(10)60066-6.

Items per page

Supplemental Content

Support Center